KraneShares MSCI All China Health Care Index ETF (KURE)
| Assets | $91.59M |
| Expense Ratio | 0.65% |
| PE Ratio | 24.69 |
| Shares Out | 5.40M |
| Dividend (ttm) | $0.18 |
| Dividend Yield | 1.05% |
| Ex-Dividend Date | Dec 17, 2024 |
| Payout Frequency | Annual |
| Payout Ratio | 26.06% |
| Volume | 11,069 |
| Open | 17.50 |
| Previous Close | 17.41 |
| Day's Range | 17.28 - 17.50 |
| 52-Week Low | 12.95 |
| 52-Week High | 20.51 |
| Beta | 0.21 |
| Holdings | 48 |
| Inception Date | Feb 1, 2018 |
About KURE
Fund Home PageThe KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is issued by KraneShares.
Top 10 Holdings
53.36% of assets| Name | Symbol | Weight |
|---|---|---|
| BEONE MEDICINES LTD | n/a | 8.64% |
| Jiangsu Hengrui Medicine Co., Ltd. | 600276 | 8.02% |
| WuXi Biologics (Cayman) Inc. | 2269 | 6.63% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 300760 | 6.22% |
| CSPC Pharmaceutical Group Limited | 1093 | 4.53% |
| Innovent Biologics, Inc. | 1801 | 4.43% |
| Akeso, Inc. | 9926 | 4.29% |
| Sino Biopharmaceutical Limited | 1177 | 4.24% |
| WuXi AppTec Co., Ltd. | 603259 | 3.42% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 600436 | 2.94% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 17, 2024 | $0.18361 | Dec 18, 2024 |
| Dec 18, 2023 | $0.11284 | Dec 20, 2023 |
| Dec 28, 2022 | $0.0104 | Dec 30, 2022 |
| Dec 29, 2021 | $4.05354 | Dec 31, 2021 |
| Dec 29, 2020 | $0.00011 | Dec 31, 2020 |
| Dec 27, 2019 | $0.0573 | Dec 31, 2019 |
Performance
KURE had a total return of 35.85% in the past year, including dividends. Since the fund's inception, the average annual return has been -2.53%.
News
China's Healthcare ETFs Outpace U.S. Competitors
When it comes to creating a well-diversified portfolio, healthcare stocks have traditionally offered a variety of benefits. As an innovative sector, healthcare companies offer the potential to build ...
Hang Seng Index: Transforming Into A Medium-Term Bearish Trend Despite Improving Services PMI From China
Sentiment remains fragile in China and Hong Kong stock market even China services activities have improved in December. Weak market breadth and a persistent bearish trend of the Chinese yuan since Nov...
China's Policy Measures: A Pivotal Week?
China's policymakers have announced a significant package of easing measures designed to lift China from a state of entrenched economic weakness. The reception from global markets has been very positi...
China's Data Dump Shows That Time Is Running Out To Achieve This Year's Growth Target
Data largely came in weaker than already cautious forecasts, and with a less supportive base effect, we will need to see a significant stimulus push to reach this year's growth target. Looking at the ...
China's Stalling Credit Market Signals an Era Of Stagnation
The latest figures published by the People's Bank of China show that credit and liquidity are stalling as demand for new loans declines. Deteriorating confidence in China's prospects explains why hous...
China's Key Growth Indicators Continue To Present A Case For Further Policy Easing
Data came in generally in line or slightly weaker than forecasts, as weak confidence continued to depress investment and consumption. New home prices fell by -0.65% MoM in July, compared to a -0.67% M...
The Chinese Economy Is In Trouble, Here Are The Warning Signs
China has been hit with two major crises as their financial and real estate sectors collapse simultaneously. Deflation, unemployment, divestiture, and lowered consumption are affecting all levels of s...
China's Credit Activity Remained Weak In July
New aggregate financing and loans both missed forecasts again in July amid high real interest rates and limited borrowing appetite. New RMB loans fell into contraction at RMB 770.8bn, lowering the yea...
China's Sluggish May Economic Data To Increase Calls For Rate Cuts
The People's Bank of China kept the one-year medium-term lending facility rate unchanged at 2.5% today, in line with market expectations. We believe that in conjunction with today's data releases and ...
China Accelerates Policy Support Rollout Amid Mixed Data
Key economic indicators are mixed in China and, in fact, were mostly weaker than expected last month. So, policymakers are now stepping up support for the property sector in particular.
China's May PMI Disappointed As Manufacturing Fell Back Into Contraction
Manufacturing sector PMI fell back into contraction amid weak orders and slowing production. Given a fairly strong positive correlation between the data, the disappointing PMI release sends a warning ...
Thinking Hard About The China Overproduction Narrative
Concerns about “overcapacity” arise primarily for goods linked to high-wage jobs, not for low-wage industries like clothing or toys. China sees its success as a result of a system that blends state co...
PBOC Held Rates Steady In March
The PBOC held the 1-year medium-term lending facility (MLF) rate at 2.5% in March. The PBOC remains on a dovish tilt, but depreciation pressure on the RMB limits room for monetary easing in China befo...
Enter The Dragon: Parsing Lunar New Year Opportunities Among Emerging Markets
China and Hong Kong markets had a humbling 2023 with equities down more than 10%. Beijing has also begun stepping up tourism and travel promotions, granting visa-free entry to 11 countries, with Singa...
China: January 2024 CPI Inflation Fell To The Lowest Level Since 2009, Likely To Mark The Bottom
China's January CPI inflation was weaker than forecast at -0.8% YoY, which marks the lowest level since September 2009. We expect this to mark the bottom of the current cycle.
China Begins Year Of The Dragon With Weak Economic Momentum
The Chinese economy is stabilising, but the only fireworks will come from the new year celebrations, which begin on February 11, as momentum remains weak. China's GDP growth for the fourth quarter ros...
China Growth Could Slow Amid Limited Policy Options
While recent policy announcements and data surprises have generated some optimism, we maintain a cautious stance on China's economic prospects. We believe weak consumption trends, a downbeat labor mar...
China Outlook: Market Rescue Welcomed, But More Needed
In response to the recent China equity market rout, policymakers vowed last week to stabilize the market through more forceful measures. Despite a very positive initial market reaction (an 8% rebound ...
